Heart Failure in Brazil and the Need to Measure and Take Action

Autores da FMUP
Participantes de fora da FMUP
- Rivas-Lasarte, M
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1071-9164, 1532-8414
- Tipo:
- Editorial Material
- Páginas:
- 651-652
- Link para outro recurso:
- www.scopus.com
Journal of Cardiac Failure Churchill Livingstone
Documentos
- Não há documentos
Filiações
Keywords
- Brazil; Heart Failure; Humans; aldosterone antagonist; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; enkephalinase inhibitor; sodium glucose cotransporter 2 inhibitor; spironolactone; Brazil; clinical outcome; Editorial; empowerment; evidence based practice; follow up; heart failure; human; patient education; prognosis; Brazil; heart failure
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023
Citar a publicação
Rivas M,Ferreira JP. Heart Failure in Brazil and the Need to Measure and Take Action. J. Card. Fail. 2024. 30(5):p. 651-652. IF:6,000. (1).